Making Life-Saving Clinical Trials Accessible to Patients

PHC Ventures is investing $100K in MyTrials.ai, a company founded by Dr. Zachary Laksman, an in-house entrepreneur and clinician with Providence Health Care, and three biomedical engineers; Omar Asaker, Tyler Connelly, and Kristian Isa. This partnership is built on a shared commitment to saving lives through enhanced patient access. 

“MyTrials.ai is at the forefront of revolutionizing clinical trial recruitment,” said Omar Asaker, CEO of MyTrials.ai. “This partnership with PHC Ventures will enable us to scale our vision, improve patient access to cutting-edge treatments, and drive meaningful advancements in health care.” 

In addition to the investment, MyTrials.ai will also leverage PHC Ventures’ incubation program, a new initiative aimed at supporting startups that are transforming health care. “PHC Ventures has all the necessary resources to help a biomedical startup be successful from concept to successful launch,” explains Vikram Devdas, Tech Director of PHC Ventures. “The new strategic  incubation program not only will provide a unique avenue for entrepreneurial clinicians in BC to scale their idea into a thriving company, improve patient outcomes and create valuable jobs in BC.” 

By combining the resources and expertise of PHC Ventures with MyTrials.ai's innovative platform, this investment will transform clinical trial recruitment and screening, while empowering individuals to easily and rapidly find cutting-edge solutions that meet their personalized needs.  

“We’re thrilled to support MyTrials.ai in transforming the clinical trial process,” said Brian Simmers, President of PHC Ventures, “This partnership allows us to accelerate innovation and improve outcomes for patients everywhere.” 

MyTrials.ai: Revolutionizing Clinical Trials 

MyTrials.ai harnesses the power of artificial intelligence (AI) to streamline and personalize the clinical trial process. Inspired by Dr. Laksman’s firsthand experiences with patients, families, and friends struggling to find viable clinical trial options, the platform aims to make trial access equitable, efficient, and user-focused. 

The current recruitment landscape is complex, costly, and inefficient. MyTrials.ai upends this paradigm by starting with the individual. The platform works to understand each person’s goals and needs, connecting them with clinical research programs that align with their preferences. This patient-first approach dramatically reduces screening time and costs, expands the pool of eligible participants, and ensures equitable access to innovative therapies. With a focus on user preferences, values, and disease understanding, MyTrials.ai makes navigating clinical trials accessible to everyone, regardless of medical background. 

AI-Driven Patient Matching 

MyTrials.ai’s innovative platform reduces recruitment costs by nearly 50% while offering a robust, user-friendly interface designed with simplicity and accessibility in mind. Patients can explore trial options using plain language, personalized filters, and tailored recommendations that fit their interests and schedules. MyTrials.ai continues to evolve to meet the needs of patients, researchers, and industry partners, leveraging the team and the platform’s experience to provide customizable solutions in the clinical trial ecosystem. 

MyTrials.ai 

MyTrials.ai is an innovative platform dedicated to revolutionizing clinical trial recruitment and matching by putting patients at the centre of the process. Designed to make clinical trials more accessible and inclusive, MyTrials.ai combines cutting-edge AI technology with a deep commitment to patient empowerment, ensuring individuals worldwide can effortlessly connect with the most advanced treatments and opportunities. 

The platform provides researchers and clinical trial organizations with streamlined tools for identifying eligible participants, reducing recruitment timelines, and improving trial outcomes. By bridging the gap between patients and groundbreaking health solutions, MyTrials.ai is shaping the future of clinical research. 

 Leadership Driving Innovation 

•  Omar Asaker, CEO — Biomedical engineer with expertise in health tech innovation.
• Dr. Zachary Laksman, CMO — Clinician-scientist specializing in patient-centric solutions.
• Tyler Connelly, CTO — Expert in software development and AI technology.
• Kristian Isa, CCO — Biomedical engineer with a focus on communication and collaboration. 

For more information, visit mytrials.ai. 

MyTrials.ai Contact: 

Omar Asaker 
President & Chief Executive Officer 
omar-asaker@mytrials.ai 

Providence Health Care Ventures 

Providence Health Care Ventures’ (PHC Ventures) new incubation program to support startups transforming health care. This program offers seed funding, access to clinical data, expert mentoring, and facilities to help startups scale from concept to production. Entrepreneurs receive crucial resources, including training in sales, marketing, finance, and fundraising, as well as weekly meetings to guide their growth. 

PHC Ventures is part of Innovarium, Providence Health Care’s innovation engine in British Columbia, Canada. Innovarium accelerates health innovation by connecting people, systems, and partners to research, develop, and implement novel solutions aimed at improving health care through collaboration and public-private partnerships. 

Visit www.phcventures.ca for more information. 

PHC Ventures Contact: 

Sara Turcotte 
Director, Communications 
sturcotte@providencehealth.bc.ca